Imaging study of brain blood vessel disease in adults
Builds a multi-center imaging cohort of people with cerebrovascular disease to study outcomes.
Plain-language title generated from the registry record
Registry title: Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease
Key facts
- Where
- Beijing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06925178, who can take part
Where in China
- Beijing Tiantan HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Beijing Tiantan Hospital
- Trial code
- NCT06925178
- Record updated
- 13 April 2025
- Original description
The aim of this study is to establish a multi-center and multi-modality imaging standard cohort of cerebrovascular disease, analyze the potential mechanisms affecting the prognosis of cerebrovascular disease based on a variety of imaging methods, and explore potential therapeutic targets.Read full original descriptionShow less
Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease
The aim of this study is to establish a multi-center and multi-modality imaging standard cohort of cerebrovascular disease, analyze the potential mechanisms affecting the prognosis of cerebrovascular disease based on a variety of imaging methods, and explore potential therapeutic targets.
Inclusion: Age between 18 and 80 years old; Onset of symptoms within 7 days; Clinical diagnosis of cerebrovascular disease (ischemic stroke or hemorrhagic stroke) confirmed by head imaging (CT or MRI); Signed informed consent form.
Exclusion: Diagnosed with non-cerebrovascular diseases (such as central nervous system infections, epilepsy, and metabolic encephalopathy); Patients with contraindications to multimodal CT or MRI, functional near-infrared imaging, or those who cannot cooperate to complete the relevant examinations; Patients with a life expectancy of less than 3 months or those who cannot complete the study follow-up due to other reasons.